Evidence map›Paper›PMID 40304788›Full record

ArticleWorld journal of urology2025

Ensuring patient safety during cystocopy: risk assessment of device reprocessing through healthcare failure mode and effects analysis.

Miriam Roncal Redin, Cristina Diaz-Agero Perez, Cornelia Bischofberger Valdes, Diego San Jose-Saras, Paloma Moreno-Nunez, Jorge Vicente-Guijarro, Jesús M Aranaz-Andres

Abstract read
In one paragraph

Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. [Critical assessment of single-use endoscopes].Urologie (Heidelberg, Germany) · 2025
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Miriam Roncal Redin *Hospital Universitario Ramón y Cajal, Ctra. de Colmenar Viejo, km. 9,100, 28034, Madrid, Spain. miriam.roncal@salud.madrid.org.
Cristina Diaz-Agero Perez *Hospital Universitario Ramón y Cajal, Ctra. de Colmenar Viejo, km. 9,100, 28034, Madrid, Spain.
Cornelia Bischofberger ValdesHospital Universitario Ramón y Cajal, Ctra. de Colmenar Viejo, km. 9,100, 28034, Madrid, Spain.
Diego San Jose-SarasHospital Universitario Ramón y Cajal, Ctra. de Colmenar Viejo, km. 9,100, 28034, Madrid, Spain.
Paloma Moreno-NunezHospital Universitario Ramón y Cajal, Ctra. de Colmenar Viejo, km. 9,100, 28034, Madrid, Spain.
Jorge Vicente-GuijarroHospital Universitario Ramón y Cajal, Ctra. de Colmenar Viejo, km. 9,100, 28034, Madrid, Spain.
Jesús M Aranaz-AndresHospital Universitario Ramón y Cajal, Ctra. de Colmenar Viejo, km. 9,100, 28034, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFlexible cystoscopy is a widely performed urological procedure, with millions conducted annually. However, cystoscope contamination rates are relatively high, ranging from 2 to 21%, and infections may go undetected. Proper reprocessing of cystoscopes is a critical step in ensuring the safe use of these devices, which underscores the importance of studying it more thoroughly. The aim of this article is to describe the stages of cystoscope reprocessing in the Urology Department of a tertiary Hospital, identifying the potential failures of the system before they occur, quantifying its risks and recommending improvement actions to enhance overall safety and efficiency. MATERIAL AND

methodsThis qualitative study was conducted using the Failure Mode and Effects Analysis methodology in different phases. First, data on structure, equipment and work processes were collected through direct observation and staff interviews. Then, processes and sub-processes were described along with their possible failures and underlying causes. Risks of this potential failures (failure modes) were quantified using the Risk Priority Number (RPN), calculated as the product of their frequency, severity and detectability. Improvement actions to mitigate failures with the highest NRP were proposed based on expert consensus and literature review. KEY FINDINGS AND LIMITATIONS: 9 processes and 11 sub-processes were identified, along with 16 failure modes. The key failure modes, those with an RPN > 100 included incorrect manual high-level disinfection, incorrect cleaning due to lack of brushing and lack of traceability. These failures were primarily caused by insufficient staff training, short intervals between procedures, and inadequate infrastructure. To address these issues, expert recommendations included providing comprehensive training for staff, improving reprocessing infrastructure by optimizing room layout, and ensuring an adequate supply of cystoscopes to reduce time constraints. Additionally, prioritizing automatic high-level disinfection and implementing a traceability system were proposed to enhance process reliability and patient safety.

conclusionInadequate organizational structure and equipment can compromise patient safety during high-care activities. After analyzing cystoscope reprocessing at our center, three critical failure modes (NPR > 100) were identified: lack of traceability, improper cleaning due to insufficient brushing, and improper manual high-level disinfection (HLD). To address these issues, we proposed actions including improve staff training, increase the cystoscope supply, and enhance the unit's infrastructure. These findings may guide other healthcare professionals in improving reprocessing safety.

Indexed as

CystoscopesCystoscopyEquipment ContaminationEquipment ReuseHealthcare Failure Mode and Effect AnalysisPatient SafetyDisinfectionEquipment FailureHumansRisk AssessmentCystoscopeFailure mode and effects analysisInfection preventionPatient safetyRisk analysisSterilization

Identifiers

PMID40304788
PMCPMC12043719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.